Registration
CHAMBER HILL STRATEGIES for BOEHRINGER-INGELHEIM PHARMACEUTICALS, INC.
Income
—
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Federal policies affecting pharmaceutical manufacturers
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER BELL New | Senate Finance Committee - Health Policy AdvisorRep. John Thune (R-SD) - Legislative Assistant |
Medicare/Medicaid MMM
Federal policies affecting pharmaceutical manufacturers
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER BELL New | Senate Finance Committee - Health Policy AdvisorRep. John Thune (R-SD) - Legislative Assistant |
Tariff (miscellaneous tariff bills) TAR
Federal policies affecting pharmaceutical manufacturers
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER BELL New | Senate Finance Committee - Health Policy AdvisorRep. John Thune (R-SD) - Legislative Assistant |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| BOEHRINGER INGELHEIM GMBH | Germany | Germany | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.